drugset / Trial / NCT05191628
Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this open, multicenter trial is to assess the impact of the use of an amniotic membrane graft on the closure of macular hole-associated retinal detachment in patients with failed previous macular surgery.
Timeline
- Start
- 2020-06-10
- Primary completion
- 2022-10-10
- Completion
- 2022-10-10
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Visio-AMTRIX | Other / unclassified | — | Other |